Raman Scattering Spectroscopy to Measure Macular Pigment
Measurement of Macular Pigment With Resonant Raman Backscattering Spectroscopy
2 other identifiers
interventional
40
1 country
1
Brief Summary
This study will evaluate the ease and reliability of Raman scattering spectroscopy, a new technique to measure the amount of the pigment lutein in the retina, the light-sensitive tissue lining the back of the eye. The highest concentrations of lutein are in the center of the retina, called the macula, which is the area most important for fine, detailed vision. The functions of lutein are not fully known. Besides absorbing blue light, it may help protect against abnormal changes in the retina, such as age-related macular degeneration. Until recently, lutein was measured using long, cumbersome, and difficult tests. This study will evaluate a new instrument that provides faster measurements. It will be tested under different conditions, such as wearing or not wearing glasses or contact lenses, or dilating or not dilating the pupil of the eye. Healthy normal volunteers between 20 and 65 years of age may be eligible for this study, which involves two visits to the NIH Clinical Center, as follows: Visit 1 - Screening
- Medical history and physical examination, including measurement of vital signs (blood pressure, pulse, temperature, and breathing rate), and examination of the head and neck, heart and lungs, and arms and legs.
- Eye examination, including eye chart test, eye pressure measurement, examination of pupils and eye movements, and examination of the retina (back part of the eye) using a strong light and magnifying lens after dilation of the pupils.
- Raman scattering spectroscopy to measure lutein. For this test, the subject looks with one eye at a brief, bright flash of bluish light (similar to a flashbulb light) from a laser. This is repeated several times. Subjects who wear glasses or contact lenses for distance vision will be tested without them and then again with a lens in front of the eye. Subjects who do not wear glasses or contact lenses will be tested before and after dilation of the pupil.
- Contrast sensitivity to assess ability to identify an object from the background and to see everyday objects. The subject looks at and identifies a variety of objects of different shapes and sizes.
- Color vision to determine the ability to identify different shades of color. The subject arranges a line of colorful discs, similar to checkers, in order of similar shades. Visit 2 - Repeat Spectroscopy Subjects return 1 week after the screening visit for a repeat Raman scattering spectroscopy to evaluate the precision of the measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started May 2003
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedFirst Submitted
Initial submission to the registry
May 7, 2003
CompletedFirst Posted
Study publicly available on registry
May 8, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2006
CompletedMarch 4, 2008
March 1, 2006
May 7, 2003
March 3, 2008
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Men and women between 18 and 75 years of age.
- Corrected visual acuity of 20/30 or better.
- Ability to understand and sign an informed consent form prior to enrollment.
You may not qualify if:
- Ocular disease, including significant explained or unexplained visual field loss.
- Ocular media opacities.
- History of epilepsy or light-triggered convulsions.
- A maximal pupillary dilation of less than 7 mm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Eye Institute (NEI)
Bethesda, Maryland, 20892, United States
Related Publications (3)
Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res. 1985;25(11):1531-5. doi: 10.1016/0042-6989(85)90123-3.
PMID: 3832576BACKGROUNDLandrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997 Jul;65(1):57-62. doi: 10.1006/exer.1997.0309.
PMID: 9237865BACKGROUNDSeddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994 Nov 9;272(18):1413-20.
PMID: 7933422BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
May 7, 2003
First Posted
May 8, 2003
Study Start
May 1, 2003
Study Completion
March 1, 2006
Last Updated
March 4, 2008
Record last verified: 2006-03